Network toxicology and multiomics reveal bisphenol A-mediated immune evasion in breast cancer

Yu Fang1, Jia-Li Yan2, Wang Zhang1

  • 1Department of Pharmacy, The Third People's Hospital of Hefei, Hefei Third Clinical College of Anhui Medical University, China.

Insights

Exposure to bisphenol A may influence breast cancer by modulating immune cells. Four genes (CCL19, CD40LG, IGLL5, KLRB1) linked to immune response were identified as potential biomarkers for risk assessment.

Area of Science:

  • Environmental toxicology
  • Cancer immunology
  • Molecular biology

Background:

  • Bisphenol A (BPA) is an environmental toxicant with potential endocrine-disrupting properties.
  • Breast cancer involves complex interactions between tumor cells and the immune microenvironment.
  • Understanding the link between environmental exposures and cancer immunity is crucial for risk assessment.

Purpose of the Study:

  • To investigate the relationship between bisphenol A exposure, immune modulation, and breast cancer prognosis.
  • To identify potential immunoregulatory genes affected by BPA exposure in breast cancer.

Main Methods:

  • Integrative analysis of BPA targets and breast cancer genes.
  • Construction and analysis of protein-protein interaction networks.
  • Survival analysis in The Cancer Genome Atlas (TCGA) and METABRIC cohorts.
  • Tumor microenvironment profiling using ESTIMATE and CIBERSORT.
  • Molecular docking to assess BPA-protein binding.

Main Results:

  • Four immunoregulatory genes (CCL19, CD40LG, IGLL5, KLRB1) were identified, associated with T cell activation and cytokine signaling.
  • Gene expression correlated with immune cell infiltration (CD8+ T cells, B cells, macrophages).
  • Higher expression of these genes predicted improved overall survival in both TCGA and METABRIC cohorts.
  • Molecular docking suggested BPA may interfere with immune signaling pathways.

Conclusions:

  • This study links environmental toxicology (BPA) to breast cancer immunity and prognosis.
  • CCL19, CD40LG, IGLL5, and KLRB1 are nominated as candidate biomarkers for BPA exposure-risk assessment.
  • Findings are correlative and warrant further mechanistic validation.

Related Concept Videos